SCHEMBL12008768

SCHEMBL12008768

O=C(O)CCN1C(=O)/C(=C\c2ccc(Cl)cc2)SC1=S

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CISD1 Q9NZ45 2/20 0.79
▸ MAOA P21397 1/20 0.79
▸ KMT2A Q03164 5/20 0.74
▸ KDM4E B2RXH2 2/20 0.74
▸ HTT P42858 1/20 0.74
▸ MAPT P10636 5/20 0.73
▸ NCOA3 Q9Y6Q9 3/20 0.73
▸ ALDH1A1 P00352 1/20 0.73
▸ PPARG P37231 1/20 0.71
▸ MITF O75030 2/20 0.70
▸ RAB9A P51151 1/20 0.70
▸ MEN1 O00255 3/20 0.69
▸ CTDSP1 Q9GZU7 2/20 0.69
▸ HIF1AN Q9NWT6 1/20 0.68
▸ AKR1B1 P15121 3/20 0.67
▸ FFAR1 O14842 1/20 0.67
▸ NPC1 O15118 1/20 0.67
▸ LMNA P02545 1/20 0.67
▸ BLM P54132 1/20 0.64
▸ PTPN1 P18031 1/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12008435 0.93 FFAR1 (0.79) CISD1MAOAKMT2AKDM4EHTT
SCHEMBL17768964 0.89 CISD1 (0.73) CISD1MAOAKMT2AKDM4EHTT
SCHEMBL12008711 0.89 CISD1 (0.81) CISD1MAOAKMT2AKDM4EHTT
SCHEMBL12008493 0.89 CISD1 (0.81) CISD1MAOAKMT2AKDM4EHTT
SCHEMBL18420883 0.89 CISD1 (0.81) CISD1MAOAKMT2AKDM4EHTT
SCHEMBL15709015 0.89 CISD1 (0.81) CISD1MAOAKMT2AKDM4EHTT
SCHEMBL30228410 0.89 MAPT (0.71) CISD1MAOAKMT2AKDM4EHTT
SCHEMBL12008506 0.89 MAPT (0.71) CISD1MAOAKMT2AKDM4EHTT
SCHEMBL22971853 0.88 CISD1 (1.00) CISD1MAOAKMT2AKDM4EHTT
SCHEMBL12008769 0.88 CISD1 (1.00) CISD1MAOAKMT2AKDM4EHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170049751-A1 OXAZOLE AND THIAZOLE COMPOUNDS AS BETA-CATENIN MODULATORS AND USES THEREOF DASGUPTA RAMANUJ (US) 2017-02-23 — — US disclosed
US-20170049751-A1 OXAZOLE AND THIAZOLE COMPOUNDS AS BETA-CATENIN MODULATORS AND USES THEREOF DASGUPTA RAMANUJ (US) 2017-02-23 — — US disclosed
US-9433611-B2 Oxazole and thiazole compounds as β-catenin modulators and uses thereof NEW YORK UNIVERSITY (US) 2016-09-06 — — US disclosed
US-9433611-B2 Oxazole and thiazole compounds as β-catenin modulators and uses thereof NEW YORK UNIVERSITY (US) 2016-09-06 — — US disclosed
US-9173871-B2 Oxazole and thiazole compounds as beta-catenin modulators and uses thereof NEW YORK UNIVERSITY (US) 2015-11-03 — — US disclosed
US-9173871-B2 Oxazole and thiazole compounds as beta-catenin modulators and uses thereof NEW YORK UNIVERSITY (US) 2015-11-03 — — US disclosed
US-20130109675-A1 OXAZOLE AND THIAZOLE COMPOUNDS AS BETA-CATENIN MODULATORS AND USES THEREOF NEW YORK UNIVERSITY 2013-05-02 — — US disclosed
US-20130109675-A1 OXAZOLE AND THIAZOLE COMPOUNDS AS BETA-CATENIN MODULATORS AND USES THEREOF NEW YORK UNIVERSITY 2013-05-02 — — US disclosed
US-20120264744-A1 OXAZOLE AND THIAZOLE COMPOUNDS AS BETA-CATENIN MODULATORS AND USES THEREOF UNITED STATES GOVERNMENT 2012-10-18 — — US disclosed
US-20120264744-A1 OXAZOLE AND THIAZOLE COMPOUNDS AS BETA-CATENIN MODULATORS AND USES THEREOF UNITED STATES GOVERNMENT 2012-10-18 — — US disclosed
US-8252823-B2 Oxazole and thiazole compounds as beta-catenin modulators and uses thereof NEW YORK UNIVERSITY (US) 2012-08-28 — — US disclosed
US-8252823-B2 Oxazole and thiazole compounds as beta-catenin modulators and uses thereof NEW YORK UNIVERSITY (US) 2012-08-28 — — US disclosed
US-20090227624-A1 Oxazole and thiazole compounds as beta-catenin modulators and uses thereof US ARMY, SECRETARY OF THE ARMY 2009-09-10 — — US disclosed
US-20090227624-A1 Oxazole and thiazole compounds as beta-catenin modulators and uses thereof US ARMY, SECRETARY OF THE ARMY 2009-09-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120264744-A1 OXAZOLE AND THIAZOLE COMPOUNDS AS BETA-CATENIN MODULATORS AND USES THEREOF CTNNB1, CTNNA1, CTNNBL1 CISD1 2475/4885MAOA 4320/4885KMT2A 4503/4885
US-20090227624-A1 Oxazole and thiazole compounds as beta-catenin modulators and uses thereof CTNNB1, CTNNA1, CTNNBL1 CISD1 2618/4885MAOA 3935/4885KMT2A 4591/4885
US-20170049751-A1 OXAZOLE AND THIAZOLE COMPOUNDS AS BETA-CATENIN MODULATORS AND USES THEREOF CTNNB1, CTNNA1, CTNNBL1 CISD1 2618/4885MAOA 3935/4885KMT2A 4591/4885
US-20130109675-A1 OXAZOLE AND THIAZOLE COMPOUNDS AS BETA-CATENIN MODULATORS AND USES THEREOF CTNNB1, CTNNA1, CTNNBL1 CISD1 2618/4885MAOA 3935/4885KMT2A 4591/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback